Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolmitriptan Nasal Spray in Acute Migraine
NCT00617747Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2002
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Zolmitriptan with Placebo (2 arms). Primary endpoint: Improvement in migraine headache pain from severe or moderate to mild or none. Started Sep 2002; status: completed.
02
Drugs
zolmitriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00617747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617747.